Michael R Ehrenstein (M R Ehrenstein)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 17

Top Venues

The Journal of experimental medicine

BMC medicine

Rheumatology advances in practice

Annals of the rheumatic diseases

University College London Hospitals NHS Foundation Trust

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University College London Hospitals NHS Foundation Trust Aug 01 1999

United Kingdom

Honorary Consultant Rheumatologist

Publications

Sara T Ibrahim, Christopher J Edwards, Michael R Ehrenstein, Bridget Griffiths, Caroline Gordon, Peter Hewins, David Jayne, Liz Lightstone, Zoe McLaren, Benjamin Rhodes, Edward M Vital, John A Reynolds
Differences in management approaches for lupus nephritis within the UK. Rheumatology advances in practice 8 (1) (2024)
Sara T Ibrahim, Christopher J Edwards, Michael R Ehrenstein, Bridget Griffiths, Caroline Gordon, Peter Hewins, David Jayne, Liz Lightstone, Zoe McLaren, Benjamin Rhodes, Edward M Vital, John A Reynolds
Differences in management approaches for lupus nephritis within the UK. Rheumatology advances in practice 8 (1) (2024)
Michael R Ehrenstein, Muhammad Shipa
SLE is not a one-size-fits-all disease. The Journal of experimental medicine 220 (6) (2023)
Peter C Taylor, Ayman Askari, Ernest H S Choy, Michael R Ehrenstein, Sara Else, Muhammad K Nisar
Approaches to optimising access to NICE-approved biologic anti-TNFs for patients with rheumatoid arthritis with moderately active disease. BMC medicine 21 (1) (2023)
Peter C Taylor, Ayman Askari, Ernest H S Choy, Michael R Ehrenstein, Sara Else, Muhammad K Nisar
Approaches to optimising access to NICE-approved biologic anti-TNFs for patients with rheumatoid arthritis with moderately active disease. BMC medicine 21 (1) (2023)
Peter C Taylor, Ayman Askari, Ernest H S Choy, Michael R Ehrenstein, Sara Else, Muhammad K Nisar
Approaches to optimising access to NICE-approved biologic anti-TNFs for patients with rheumatoid arthritis with moderately active disease. BMC medicine 21 (1) (2023)
Michael R Ehrenstein, Muhammad Shipa
SLE is not a one-size-fits-all disease. The Journal of experimental medicine 220 (6) (2023)
Michael R Ehrenstein, Muhammad Shipa
SLE is not a one-size-fits-all disease. The Journal of experimental medicine 220 (6) (2023)
Peter C Taylor, Ayman Askari, Ernest H S Choy, Michael R Ehrenstein, Sara Else, Muhammad K Nisar
Approaches to optimising access to NICE-approved biologic anti-TNFs for patients with rheumatoid arthritis with moderately active disease. BMC medicine 21 (1) (2023)
Michael R Ehrenstein, Muhammad Shipa
SLE is not a one-size-fits-all disease. The Journal of experimental medicine 220 (6) (2023)
Muhammad R A Shipa, Lawrence Langley, Benjamin Sacks, Su-Ann Yeoh, M D Mainuddin, Dev Mukerjee, Madhura Castelino, Michael R Ehrenstein
Increased erythrocyte mean corpuscular volume by methotrexate predicts clinical response in psoriatic arthritis. Rheumatology (Oxford, England) 61 (9) (2022)
Muhammad Ruhu Amin Shipa, Su-Ann Yeoh, Andrew Embleton-Thirsk, Dev Mukerjee, Michael R Ehrenstein
The synergistic efficacy of hydroxychloroquine with methotrexate is accompanied by increased erythrocyte mean corpuscular volume. Rheumatology (Oxford, England) (2021)
Muhammad Ruhul Amin Shipa, Andrew Embleton-Thirsk, Mariea Parvaz, Liliana Ribeiro Santos, Patrick Muller, Kashfia Chowdhury, David A Isenberg, Caroline J Doré, Caroline Gordon, Michael R Ehrenstein, null null
Effectiveness of Belimumab After Rituximab in Systemic Lupus Erythematosus : A Randomized Controlled Trial. Annals of internal medicine (2021)
Muhammad Ruhul Amin Shipa, Raj Amarnani, Su-Ann Yeoh, M D Mainuddin, Michael R Ehrenstein
Early reduction in circulating monocyte count predicts maintenance of remission in patients with rheumatoid arthritis treated with anti-TNF therapy. Annals of the rheumatic diseases 80 (12) (2021)
Patrick Muller, Ipek Gurol-Urganci, Joanna C Roper, Michael R Ehrenstein, Jan H P van der Meulen, Swati Jha
Impact of a mid-urethral synthetic mesh sling on long-term risk of systemic conditions in women with stress urinary incontinence: a national cohort study. BJOG : an international journal of obstetrics and gynaecology (2021)
Mandy Greenwood, Muhammad Shipa, Su-Ann Yeoh, Euthalia Roussou, Dev Mukerjee, Michael R Ehrenstein
Methotrexate reduces withdrawal rates of TNF inhibitors due to ineffectiveness in rheumatoid arthritis but only in patients who are seropositive. Annals of the rheumatic diseases 79 (11) (2020)
Alexis Jones, Patrick Muller, Caroline J Dore, Felicia Ikeji, Emilia Caverly, Kashfia Chowdhury, David Alan Isenberg, Caroline Gordon, Michael R Ehrenstein
Belimumab after B cell depletion therapy in patients with systemic lupus erythematosus (BEAT Lupus) protocol: a prospective multicentre, double-blind, randomised, placebo-controlled, 52-week phase II clinical trial. BMJ open 9 (12) (2019)

Michael R Ehrenstein.css-eqlu8i{font-size:small;padding-left:4px;} (M R Ehrenstein)

Publication Activity (10 Years)

Top Topics

Top Venues

Michael R Ehrenstein (M R Ehrenstein)